Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Charles River Laboratories International Inc CRL

Technology Scientific & Technical Instruments
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its... see more

Recent & Breaking News (NYSE:CRL)

Charles River Laboratories to Present at William Blair and Jefferies Conferences

Business Wire June 3, 2024

Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development

Business Wire May 30, 2024

Charles River Laboratories Announces First-Quarter 2024 Results

Business Wire May 9, 2024

Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP

Business Wire May 2, 2024

Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally

Business Wire April 22, 2024

Notice to Long-Term Charles River Laboratories International, Inc. (CRL) Shareholders: Grabar Law Office Is Investigating Claims on Your Behalf

Newsfile April 18, 2024

Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing

Business Wire April 16, 2024

STOCK INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Charles River Laboratories Intl. (CRL) and Encourages Long-Term Investors to Contact the Firm

Newsfile April 15, 2024

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Charles River Laboratories International, Inc. (CRL)

Newsfile April 15, 2024

Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call

Business Wire April 12, 2024

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

Business Wire April 11, 2024

Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics

Business Wire April 9, 2024

Charles River to Perform Plasmid Production for Ship of Theseus

Business Wire April 4, 2024

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Charles River Laboratories Intl. (CRL) and Encourages Long-Term Investors to Contact the Firm for Additional Information

Newsfile April 2, 2024

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Charles River Laboratories International, Inc. (CRL)

Newsfile April 2, 2024

Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024

Business Wire April 1, 2024

Charles River Laboratories Publishes 2023 Corporate Citizenship Report

Business Wire March 27, 2024

Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine

Business Wire March 21, 2024

Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration

Business Wire March 14, 2024

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Business Wire March 12, 2024